Tellgen Corp
SZSE:300642
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tellgen Corp
SZSE:300642
|
CN |
|
V
|
Vidente Co Ltd
KOSDAQ:121800
|
KR |
|
Phibro Animal Health Corp
NASDAQ:PAHC
|
US |
|
Beaglee Inc
TSE:3981
|
JP |
|
Hung Hing Printing Group Ltd
HKEX:450
|
HK |
|
Japan Real Estate Investment Corp
TSE:8952
|
JP |
Tellgen Corp
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 810 full-time employees. The company went IPO on 2017-04-21. The firm's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 810 full-time employees. The company went IPO on 2017-04-21. The firm's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.
